Skip to content
healthcare.dev

Oxybutynin Chloride Extended Release

NDC 50268-629, Oxybutynin Chloride, tablet, extended release, from AvPAK.

Product NDC
50268-629
Status
Listed
Labeler
AvPAK
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078503
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50268-629 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE15 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
50268-629-135026806291330 BLISTER PACK in 1 BOX (50268-629-13) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-629-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/242b4766-bc2b-0073-d72d-1bf879bbee24
  • NADAC price for package 50268062913

    GET /v1/drugs/nadac/50268062913

Use it

Look up 50268-629 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50268-629 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50268-629. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.